Monthly Meeting
Local Seminars
The Nucleus
Contact Us



Medicinal Chemistry Group
Our Mission
The mission of the medicinal chemistry group is to advance knowledge and understanding of drug discovery research by organizing world class quality symposia.
Our meetings provide our attendees with access to top quality science presenters and offer unique networking connectivity with thought leaders in the scientific community.
Our members work at the forefront of the life science sector and are constantly striving to bring new medicines and therapies forward to the clinic to meet unmet need.

Volunteer Opportunities
The Medicinal chemistry group will be interested in volunteers to assist with annual symposium specifically for contacting potential vendors and fund-raising efforts. Please contact the med chem chair, Raj Rajur at, if interested.

Who are we?
  Dr. Raj (SB) Rajur, Chair
  Mark Ashwell
  Nimbus Therapeutics
  Daniel Elbaum
  Andrew Scholte
  Jeremy Green
  Blaise Lippa
  Morphic Therapeutic
  Adrian Hobson
  Alan Rigby
  Warp Drive Bio

Medicinal Chemistry Group Hosts Symposium on The Future of Anti-Infectives

By Mindy Levine
On Thursday September 13, 2018, approximately 70 medicinal chemists (and other chemists interested in medicinal chemistry) gathered together at Takeda Pharmaceuticals for a half-day symposium on the topic of “The Future of Anti-infectives.” This symposium was sponsored by Takeda Pharmaceuticals and was organized by the Medicinal Chemistry Group of the Northeastern Section of the American Chemical Society.
The medicinal chemistry group, organized by Dr. Raj Rajur of Creagen Bio and Dr. Andrew Scholte of Sanofi,
hosts half-day symposia twice a year, in September and in December, at a variety of pharmaceutical companies throughout the greater Boston area.
The full speaker lineup for the September event is shown below:
Afternoon speakers:
  • Kim Lewis, Northeastern University, Title: Reviving Antibiotic Discovery from Natural Products
  • Thomas Durand Reville, Entasis, Title: The rational design and discovery of ETX2514, a novel broad-spectrum β-lactamase inhibitor for the treatment of Gram-negative infections
  • Roger Clark, Macrolide, Title: Novel Macrolides for Gram-Negative Infections
After the afternoon speakers, there was a break for social hour and dinner, followed by the plenary evening lecture presented by Jacques Dumas of Tetraphase. The title of the talk was “TP-6076: taking chemistry to the next level to beat superbug.”
Overall, the attendees had uniformly positive things to say about the symposium, with attendees highlighting
the timeliness of the topic, the relevance to their careers, and the important networking opportunities provided through attending these symposia.
Stay tuned for the next medicinal chemistry symposium, coming in December 2018!